Global Albumin Market Size To Exceed USD 9.6 Billion By
The Global Albumin Market Size was valued at USD 6.1 Billion in 2022 and the Worldwide Albumin Market Size is expected to reach USD 9.6 Billion by 2032,...
Stay updated with breaking news from Infection Type. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Global Albumin Market Size was valued at USD 6.1 Billion in 2022 and the Worldwide Albumin Market Size is expected to reach USD 9.6 Billion by 2032,...
/PRNewswire/ -- Allied Market Research published a report, titled, "Anthelmintic Drugs Market by Drug Class (Benzimidazoles, Macrocyclic Lactones,...
/PRNewswire/ -- The "Surgical Site Infection Control Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been...
Dublin, Oct. 27, 2023 (GLOBE NEWSWIRE) -- The
FLORHAM PARK, N.J., September 07, 2023--Shionogi Inc., the United States subsidiary of Shionogi & Co., Ltd., (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.), announced the upcoming presentation of new data at IDWeek 2023 (October 11-15, 2023) on its investigational oral antiviral for COVID-19, ensitrelvir (Generic name: ensitrelvir fumaric acid, Code No.: S-217622, hereafter "ensitrelvir"), and Fetroja® (cefiderocol), an antibiotic marketed under the brand name Fetcro